Services do NOT include

Enhanced analysis (ICS, luminex, neutralisation assays), challenge studies.

Possible Output

Project management, raw data for clinical follow-up, tolerability assessment, CBC, blood chemistry, antibody binding and ELISPOT, cryopreserved plasma, serum, mucosal fluids and cells.

Sample Requirements - input of users

Immunogen and adjuvant - if any - with specification datasheets.

Lead Scientist

Raphael Ho Tsong Fang

Description of service

Immunogenicity study. Applicants are encouraged to contact the Lead Scientist before submitting the request for access to this service.


6 months (max), depending on the immunisation schedule


Raphael Ho Tsong Fang


This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative